fundvisualizer.com

Cullen Value ICVLVX

Performance (before sales charge)

As of 08/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 06/30/2022
Stock
89.25%
Non-U.S. Stock
10.73%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.01%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 06/30/2022

Basic materials

0.00%

Consumer cyclical

7.09%

Financial services

17.91%

Real estate

0.00%

Consumer defensive

7.14%

Health care

24.41%

Utilities

0.00%

Communication services

6.27%

Energy

6.77%

Industrials

14.84%

Technology

8.54%

Top 10 holdings

As of 06/30/2022

Pfizer Inc
5.01%
Bristol-Myers Squibb Co
4.80%
Merck & Co Inc
4.45%
Allstate Corp
3.81%
Arrow Electronics Inc
3.60%
Chevron Corp
3.48%
General Dynamics Corp
3.43%
Raytheon Technologies Corp
3.40%
JPMorgan Chase & Co
3.35%
Chubb Ltd
3.34%
Fund assets

$23.22 Million

Share class

Inst

Morningstar category

Large Value

Expense ratio

0.76%

Investment objective

Growth and Income

Documents